Severe exacerbation of psoriatic arthritis during treatment with efalizumab. A case report [6]

Acta Dermato-Venereologica

Volumn 86, Issue 5, 2006, Pages 456-457

  Bang, Bo ^a   Gniadecki, Robert ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB; INFLIXIMAB; METHOTREXATE; PREDNISOLONE; STEROID;

ADULT; ANAMNESIS; BONE SCINTISCANNING; CASE REPORT; DISEASE EXACERBATION; HEADACHE; HUMAN; INCIDENCE; LABORATORY TEST; LETTER; MALE; PAPULAR RASH; PRIORITY JOURNAL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS; TREATMENT OUTCOME;

ADULT; ANTIBODIES, MONOCLONAL; ARTHRITIS, PSORIATIC; HUMANS; MALE; PSORIASIS;

EID: 33748996745     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0122     Document Type: Letter

References (4)

1. Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, et al. Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005; 53: 573-577.
2. Moll JMH, Wright V. Psoriatic arthritis. Semin Arthritis Rheumatism 1973; 3: 55-78.
3. Zachariae H. Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol 2003; 4: 441-447.
4. Jullien D, Prinz JC, Langley RG, Caro I, Dummer W, Joshi A, et al. T-cell modulation for the treatment of chronic plaque psoriasis with efalizumab. Dermatology 2004; 208: 297-306.